Trial Profile
Diabetogenicity of Cyclosporine and Tacrolimus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Ciclosporin (Primary) ; Tacrolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms CSATAC
- 07 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2010 Planned end date changed from 1 Sep 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.